Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Clinical characteristics of the subjects

From: Denoised recurrence label-based deep learning for prediction of postoperative recurrence risk and sorafenib response in HCC

Variable

Training set

Test set

Number (n = 293)

Frequency (%)

Number (n = 73)

Frequency (%)

Age

 ≤ 50

139

47.4

38

52.1

 > 50

154

52.5

35

47.9

Gender

 Male

248

84.6

62

84.9

 Female

45

15.4

11

15.1

HBsAg

 + 

268

91.5

67

91.8

 − 

25

8.5

6

8.2

AFP

    

 + 

201

68.6

49

67.1

− 

92

31.4

24

32.9

Tumor diameter

 ≤ 5 cm

202

68.9

54

74.0

 > 5 cm

91

31.1

19

26.0

BCLC stage

 I

124

42.3

29

39.7

 II

169

57.7

44

60.3

Vascular invasion

 + 

108

36.9

31

42.5

 − 

185

63.1

42

57.5